Stem cell therapy in chronic obstructive pulmonary disease. seeking the prometheus effect

Current Drug Targets

Volumn 14, Issue 2, 2013, Pages 246-252

  Tzouvelekis, Argyris ^a   Laurent, Geoff ^b,c   Bouros, Demosthenes ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

COPD; Endothelial progenitors; Epithelial progenitors; Mesenchymal stem cells stem cells; Therapy

Indexed keywords

RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL REGENERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COMORBIDITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMAN; IMMUNOMODULATION; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS WALL; LUNG EMPHYSEMA; LUNG ENDOTHELIUM; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; STEM CELL TRANSPLANTATION; THERAPY EFFECT;

ANIMALS; APOPTOSIS; CLINICAL TRIALS AS TOPIC; EPITHELIAL CELLS; HUMANS; INFLAMMATION; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGENERATIVE MEDICINE; RESEARCH DESIGN; STEM CELL TRANSPLANTATION;

EID: 84873150798     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450111314020009     Document Type: Article

References (54)

1. Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease 2011. Global Initiative for Chronic obstructive Lung Disease (GOLD) www.goldcopd.com. 2011.
2. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 2010; 7(3): e1000220.
3. Barnes PJ, Adcock IM. Chronic obstructive pulmonary disease and lung cancer: a lethal association. Am J Respir Crit Care Med 2011; 184(8): 866-7.
4. Kirkham PA, Caramori G, Casolari P, et al. Oxidative stressinduced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 184(7): 796-802.
5. Barnes PJ. Small airways in COPD. NEnglJMed 2004; 350(26): 2635-7.
6. Paredi P, Barnes PJ. The airway vasculature: recent advances and clinical implications. Thorax 2009; 64(5): 444-50.
7. Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? RespirRes 2012; 13: 3.
8. Hind M, Maden M. Is a regenerative approach viable for the treatment of COPD? BrJPharmacol 2011; 163(1): 106-15.
9. Rankin S. Mesenchymal stem cells. Thorax 2012; 67(6): 565-6.
10. Rankin SM. Chemokines and adult bone marrow stem cells. ImmunolLett 2012; 145(1-2): 47-54.
11. Barbera JA, Peinado VI. Vascular progenitor cells in chronic obstructive pulmonary disease. ProcAmThoracSoc 2011; 8(6): 528-34.
12. Arciniegas E, Neves CY, Carrillo LM, Zambrano EA, Ramirez R. Endothelial-mesenchymal transition occurs during embryonic pulmonary artery development. Endothelium 2005; 12(4): 193-200.
13. Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. AmJPhysiol Lung Cell MolPhysiol 2007; 293(1): L1-L8.
14. Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q. Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. IntJExpPathol 2006; 87(6): 463-74.
15. Luan Y, Zhang ZH, Wei DE, Lu Y, Wang YB. Effects of autologous bone marrow mononuclear cells implantation in canine model of pulmonary hypertension. CircJ 2012; 76(4): 977-85.
16. Raoul W, Wagner-Ballon O, Saber G, et al. Effects of bone marrow-derived cells on monocrotaline-and hypoxia-induced pulmonary hypertension in mice. RespirRes 2007; 8: 8.
17. Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. JAmCollCardiol 2007; 49(7): 741-52.
18. Fadini GP, Schiavon M, Cantini M, et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006; 24(7): 1806-13.
19. Huertas A, Palange P. Circulating endothelial progenitor cells and chronic pulmonary diseases. EurRespirJ 2011; 37(2): 426-31.
20. Palange P, Testa U, Huertas A, et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. EurRespirJ 2006; 27(3): 529-41.
21. Huertas A, Testa U, Riccioni R, et al. Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI. Respir Physiol Neurobiol 2010; 170(1): 23-31.
22. Caramori G, Rigolin GM, Mazzoni F, Leprotti S, Campioni P, Papi A. Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD. Thorax 2010; 65(6): 554-5.
23. Sala E, Villena C, Balaguer C, et al. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung 2010; 188(4): 331-8.
24. Takahashi T, Suzuki S, Kubo H, Yamaya M, Kurosawa S, Kato M. Impaired endothelial progenitor cell mobilization and colonyforming capacity in chronic obstructive pulmonary disease. Respirology 2011; 16(4): 680-7.
25. Marsboom G, Pokreisz P, Gheysens O, et al. Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension. Stem Cells 2008; 26(4): 1017-26.
26. Peinado VI, Ramirez J, Roca J, Rodriguez-Roisin R, Barbera JA. Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2006; 34(3): 257-63.
27. Toshner M, Voswinckel R, Southwood M, et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med 2009; 180(8): 780-7.
28. Wang XX, Zhang FR, Shang YP, et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007; 49(14): 1566-71.
29. Zhu JH, Wang XX, Zhang FR, et al. Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. PediatrTransplant 2008; 12(6): 650-5.
30. Crystal RG, Randell SH, Engelhardt JF, Voynow J, Sunday ME. Airway epithelial cells: current concepts and challenges. ProcAmThoracSoc 2008; 5(7): 772-7.
31. Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 2011; 81(4): 265-84.
32. Barnes PJ. Emerging pharmacotherapies for COPD. Chest 2008; 134(6): 1278-86.
33. Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem cells. N Engl J Med 2011; 364(19): 1795-806.
34. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. AmJPhysiol 1996; 270(2 Pt 1): L305-L10.
35. McGowan S, Jackson SK, Jenkins-Moore M, Dai HH, Chambon P, Snyder JM. Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers. Am J Respir Cell MolBiol 2000; 23(2): 162-7.
36. Roth MD, Connett JE, D'Armiento JM, et al. Feasibility of retinoids for the treatment of emphysema study. Chest 2006; 130(5): 1334-45.
37. Mao JT, Goldin JG, Dermand J, et al. A pilot study of all-transretinoic acid for the treatment of human emphysema. AmJRespirCrit Care Med 2002; 165(5): 718-23.
38. Tzouvelekis A, Antoniadis A, Bouros D. Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med 2011; 17(5): 368-73.
39. Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell ResTher 2010; 1(2): 19.
40. Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. CurrOpinOrgan Transplant 2010; 15(1): 86-91.
41. Kondo K, Shintani S, Shibata R, et al. Implantation of adiposederived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2009; 29(1): 61-6.
42. Garcia-Gomez I, Elvira G, Zapata AG, et al. Mesenchymal stem cells: biological properties and clinical applications. ExpertOpinBiolTher 2010; 10(10): 1453-68.
43. Jones CP, Rankin SM. Bone marrow-derived stem cells and respiratory disease. Chest 2011; 140(1): 205-11.
44. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. ExpHematol 2009; 37(12): 1445-53.
45. Kotton DN, Fine A. Lung stem cells. Cell Tissue Res 2008; 331(1): 145-56.
46. Kotton DN, Fabian AJ, Mulligan RC. Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell MolBiol 2005; 33(4): 328-34.
47. Moodley Y, Atienza D, Manuelpillai U, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009; 175(1): 303-13.
48. Sueblinvong V, Loi R, Eisenhauer PL, et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med 2008; 177(7): 701-11.
49. Traktuev DO, Prater DN, Merfeld-Clauss S, et al. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 2009; 104(12): 1410-20.
50. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179(3): 1855-63.
51. Schweitzer KS, Johnstone BH, Garrison J, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011; 183(2): 215-25.
52. Selman M, Pardo A, Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med 2008; 5(3): e62.
53. Hare JM, Traverse JH, Henry TD, et al. A randomized, doubleblind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am CollCardiol 2009; 54(24): 2277-86.
54. Ribeiro-Paes JT, Bilaqui A, Greco OT, et al. Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. Int J Chron Obstruct Pulmon Dis 2011; 6: 63-71.